4
The mylife
™
Unio
™
Cara blood glucose monitoring system is intended for in-vitro (outside the body) diagnostic use
for self-testing. The coding of the test strips is automatically detected. The test result is plasma equivalent
and achieved by using (a) fresh capillary whole blood that may be drawn from the fingertip, palm or forearm,
(b) venous whole blood samples and (c) arterial whole blood samples.
You may consult your healthcare professional for instructions on how to use the system correctly. Our customer
support staff are available to assist you. Healthcare professionals may use the mylife
™
Unio
™
Cara blood glucose
monitoring system for surveillance of the blood glucose levels of patients in medical facilities.
For a better understanding of this user guide, the mylife
™
Unio
™
Cara blood glucose monitoring system will be
referred to as BGMS; the mylife
™
Unio
™
Cara blood glucose meter as meter; the mylife
™
SoftCase as SoftCase;
the mylife
™
Unio
™
test strips as test strips; the mylife
™
AutoLance
™
lancing device as lancing device; the mylife
™
Lancets as lancets; the mylife
™
ControlGDH control solution as control solution; the mylife
™
App as app and
the smartphone or personal computer as mobile device.
Intended use